A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion
- PMID: 34873187
- PMCID: PMC8648778
- DOI: 10.1038/s41598-021-02641-0
A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion
Abstract
No single reliable parameter exists to assess liver graft function of extended criteria donors during ex-vivo normothermic machine perfusion (NMP). The liver maximum capacity (LiMAx) test is a clinically validated cytochromal breath test, measuring liver function based on 13CO2 production. As an innovative concept, we aimed to integrate the LiMAx breath test with NMP to assess organ function. Eleven human livers were perfused using NMP. After one hour of stabilization, LiMAx testing was performed. Injury markers (ALT, AST, miR-122, FMN, and Suzuki-score) and lactate clearance were measured and related to LiMAx values. LiMAx values ranged between 111 and 1838 µg/kg/h, and performing consecutive LiMAx tests during longer NMP was feasible. No correlation was found between LiMAx value and miR-122 and FMN levels in the perfusate. However, a significant inverse correlation was found between LiMAx value and histological injury (Suzuki-score, R = - 0.874, P < 0.001), AST (R = - 0.812, P = 0.004) and ALT (R = - 0.687, P = 0.028). Furthermore, a significant correlation was found with lactate clearance (R = 0.683, P = 0.043). We demonstrate, as proof of principle, that liver function during NMP can be quantified using the LiMAx test, illustrating a positive correlation with traditional injury markers. This new breath-test application separates livers with adequate cytochromal liver function from inadequate ones and may support decision-making in the safe utilization of extended criteria donor grafts.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial.Ann Surg. 2019 Nov;270(5):906-914. doi: 10.1097/SLA.0000000000003540. Ann Surg. 2019. PMID: 31633615 Clinical Trial.
-
Ex Situ Machine Perfusion of Human Donor Livers via the Surgically Reopened Umbilical Vein: A Proof of Concept.Transplantation. 2019 Oct;103(10):2130-2135. doi: 10.1097/TP.0000000000002615. Transplantation. 2019. PMID: 30801511 Free PMC article.
-
Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older Donors.Liver Transpl. 2019 Mar;25(3):436-449. doi: 10.1002/lt.25362. Liver Transpl. 2019. PMID: 30362649 Clinical Trial.
-
Normothermic machine perfusion for liver transplantation: current state and future directions.Curr Opin Organ Transplant. 2024 Jun 1;29(3):186-194. doi: 10.1097/MOT.0000000000001141. Epub 2024 Mar 14. Curr Opin Organ Transplant. 2024. PMID: 38483109 Review.
-
Impact of machine perfusion preservation of liver grafts from donation after cardiac death.Transplant Proc. 2014 May;46(4):1099-103. doi: 10.1016/j.transproceed.2013.11.135. Transplant Proc. 2014. PMID: 24815138 Review.
Cited by
-
Mitochondrial DNA levels in perfusate and bile during ex vivo normothermic machine correspond with donor liver quality.Heliyon. 2024 Feb 24;10(5):e27122. doi: 10.1016/j.heliyon.2024.e27122. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463874 Free PMC article.
-
Liver function maximum capacity test during normothermic regional perfusion predicts graft function after transplantation.EPMA J. 2024 Jul 16;15(3):545-558. doi: 10.1007/s13167-024-00371-7. eCollection 2024 Sep. EPMA J. 2024. PMID: 39239110 Free PMC article.
-
Cytochrome P450 2E1 predicts liver functional recovery from donation after circulatory death using air-ventilated normothermic machine perfusion.Sci Rep. 2022 May 6;12(1):7446. doi: 10.1038/s41598-022-11434-y. Sci Rep. 2022. PMID: 35523980 Free PMC article.
-
Air-ventilated normothermic machine perfusion alleviates hepatic injury from DCD rat through CYP1A2.Heliyon. 2023 Aug 19;9(8):e19150. doi: 10.1016/j.heliyon.2023.e19150. eCollection 2023 Aug. Heliyon. 2023. PMID: 37654459 Free PMC article.
-
Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4.Front Pharmacol. 2024 May 16;15:1404938. doi: 10.3389/fphar.2024.1404938. eCollection 2024. Front Pharmacol. 2024. PMID: 38818378 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials